Literature DB >> 9678691

Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid.

F Sano1, K Tsuji, N Kunika, T Takeuchi, K Oyama, S Hasegawa, M Koike, M Takahashi, M Ishida.   

Abstract

We report a rare case of pseudotumor cerebri associated with all-trans retinoic acid (ATRA) treatment of acute promyelocytic leukemia (APL). An 18-year-old male was admitted to our hospital complaining of palpitations and shortness of breath; he was found to have APL. The administration of ATRA and chemotherapy was started. After 23 days, he complained of nausea, headache and double vision. Computed tomography and magnetic resonance imaging of the head showed no intracranial abnormalities. Bilateral papilledema, a symptom of increased intracranial pressure, was noted. A diagnosis of pseudotumor cerebri was made. Symptoms were improved by administration of glycerin and the discontinuation of ATRA. After 29 days, a complete remission was achieved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678691     DOI: 10.2169/internalmedicine.37.546

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria.

Authors:  Catherine C Coombs; Lisa M DeAngelis; James H Feusner; Jacob M Rowe; Martin S Tallman
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-11-22

Review 2.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  A Case of Acute Myeloid Leukaemia Presenting as Subacute Intracranial Hypertension in a Young Adult.

Authors:  Francis Carr; Kimberley Tan; William Stevenson; Kate Ahmad
Journal:  Neuroophthalmology       Date:  2018-08-23

4.  All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.

Authors:  Dylan Holmes; Prakash Vishnu; Russell K Dorer; David M Aboulafia
Journal:  Case Rep Oncol Med       Date:  2012-06-03

5.  High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure.

Authors:  Morgan B Smith; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Meir Wetzler; Craig W Freyer
Journal:  Leuk Res Rep       Date:  2014-07-30

6.  Unusual causes of papilledema: Two illustrative cases.

Authors:  Ha Son Nguyen; Kathryn M Haider; Laurie L Ackerman
Journal:  Surg Neurol Int       Date:  2013-04-18

7.  Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013.

Authors:  Katia Borgia Barbosa Pagnano; Eduardo Magalhães Rego; Sandra Rohr; Maria de Lourdes Chauffaille; Rafael Henriques Jacomo; Rosane Bittencourt; Ana Beatriz Firmato; Evandro Maranhão Fagundes; Raul Antonio Moraes Melo; Wanderley Bernardo
Journal:  Rev Bras Hematol Hemoter       Date:  2014

8.  All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia.

Authors:  T M Anoop; Nidhi Jain; Sreejith G Nair; Geetha Narayanan
Journal:  J Neurosci Rural Pract       Date:  2014-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.